Clinical Trial Update: TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning [NA]

View source ↗

Summary

This clinical trial update describes an ongoing study evaluating the fidelity between 99mTc-MAA and Y90-microspheres hepatic distribution for dosimetry-based tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TriNav Infusion System

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Liver Cancer | NA | Status: ACTIVE_NOT_RECRUITING